Atrial fibrillation complicating acute coronary syndromes

Sean D. Pokorney, Meena Rao, Kent R. Nilsson, Jonathan P. Piccini

Research output: Contribution to journalReview article

Abstract

Atrial fibrillation frequently complicates myocardial infarction. Patients with atrial fibrillation complicating acute coronary syndrome have increased morbidity and mortality relative to patients that remain in normal sinus rhythm. No studies have identified a mortality benefit to rhythm control compared with rate control in the setting of acute coronary syndrome. Stroke prevention should be pursued with oral anticoagulation therapy, although the majority of patients with atrial fibrillation associated with acute coronary syndrome receive only antiplatelet therapy. There are several novel oral anticoagulant therapies now available, but these agents have not been well studied in combination with dual antiplatelet therapy. Therefore, warfarin as part of triple therapy is the most conservative approach until additional data becomes available.

Original languageEnglish (US)
Pages (from-to)98-109
Number of pages12
JournalJournal of Atrial Fibrillation
Volume5
Issue number3
StatePublished - Oct 1 2012

Fingerprint

Acute Coronary Syndrome
Atrial Fibrillation
Therapeutics
Mortality
Warfarin
Anticoagulants
Stroke
Myocardial Infarction
Morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pokorney, S. D., Rao, M., Nilsson, K. R., & Piccini, J. P. (2012). Atrial fibrillation complicating acute coronary syndromes. Journal of Atrial Fibrillation, 5(3), 98-109.

Atrial fibrillation complicating acute coronary syndromes. / Pokorney, Sean D.; Rao, Meena; Nilsson, Kent R.; Piccini, Jonathan P.

In: Journal of Atrial Fibrillation, Vol. 5, No. 3, 01.10.2012, p. 98-109.

Research output: Contribution to journalReview article

Pokorney, SD, Rao, M, Nilsson, KR & Piccini, JP 2012, 'Atrial fibrillation complicating acute coronary syndromes', Journal of Atrial Fibrillation, vol. 5, no. 3, pp. 98-109.
Pokorney, Sean D. ; Rao, Meena ; Nilsson, Kent R. ; Piccini, Jonathan P. / Atrial fibrillation complicating acute coronary syndromes. In: Journal of Atrial Fibrillation. 2012 ; Vol. 5, No. 3. pp. 98-109.
@article{9e809f4e888f4371a631d2609bca5afb,
title = "Atrial fibrillation complicating acute coronary syndromes",
abstract = "Atrial fibrillation frequently complicates myocardial infarction. Patients with atrial fibrillation complicating acute coronary syndrome have increased morbidity and mortality relative to patients that remain in normal sinus rhythm. No studies have identified a mortality benefit to rhythm control compared with rate control in the setting of acute coronary syndrome. Stroke prevention should be pursued with oral anticoagulation therapy, although the majority of patients with atrial fibrillation associated with acute coronary syndrome receive only antiplatelet therapy. There are several novel oral anticoagulant therapies now available, but these agents have not been well studied in combination with dual antiplatelet therapy. Therefore, warfarin as part of triple therapy is the most conservative approach until additional data becomes available.",
author = "Pokorney, {Sean D.} and Meena Rao and Nilsson, {Kent R.} and Piccini, {Jonathan P.}",
year = "2012",
month = "10",
day = "1",
language = "English (US)",
volume = "5",
pages = "98--109",
journal = "Journal of Atrial Fibrillation",
issn = "1941-6911",
publisher = "Cardiofront, Inc.",
number = "3",

}

TY - JOUR

T1 - Atrial fibrillation complicating acute coronary syndromes

AU - Pokorney, Sean D.

AU - Rao, Meena

AU - Nilsson, Kent R.

AU - Piccini, Jonathan P.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Atrial fibrillation frequently complicates myocardial infarction. Patients with atrial fibrillation complicating acute coronary syndrome have increased morbidity and mortality relative to patients that remain in normal sinus rhythm. No studies have identified a mortality benefit to rhythm control compared with rate control in the setting of acute coronary syndrome. Stroke prevention should be pursued with oral anticoagulation therapy, although the majority of patients with atrial fibrillation associated with acute coronary syndrome receive only antiplatelet therapy. There are several novel oral anticoagulant therapies now available, but these agents have not been well studied in combination with dual antiplatelet therapy. Therefore, warfarin as part of triple therapy is the most conservative approach until additional data becomes available.

AB - Atrial fibrillation frequently complicates myocardial infarction. Patients with atrial fibrillation complicating acute coronary syndrome have increased morbidity and mortality relative to patients that remain in normal sinus rhythm. No studies have identified a mortality benefit to rhythm control compared with rate control in the setting of acute coronary syndrome. Stroke prevention should be pursued with oral anticoagulation therapy, although the majority of patients with atrial fibrillation associated with acute coronary syndrome receive only antiplatelet therapy. There are several novel oral anticoagulant therapies now available, but these agents have not been well studied in combination with dual antiplatelet therapy. Therefore, warfarin as part of triple therapy is the most conservative approach until additional data becomes available.

UR - http://www.scopus.com/inward/record.url?scp=84867903908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867903908&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:84867903908

VL - 5

SP - 98

EP - 109

JO - Journal of Atrial Fibrillation

JF - Journal of Atrial Fibrillation

SN - 1941-6911

IS - 3

ER -